Rapamycin and Pharmacogenomics in Niemann-Pick C

from JIMD Podcasts · host Journal of Inherited Metabolic Disease

A study of rapamycin in Niemann-Pick C raises an important question: what if the success of a treatment depends on a patient's wider genetic background? Dr Andrés Klein discusses pharmacogenomics, modifier genes and why precision medicine may need to go far beyond making the diagnosis. A Rapamycin Pharmacogenomic Approach for the Childhood Dementia Niemann-Pick C Benjamín Szenfeld, et al https://doi.org/10.1002/jimd.70214

Episode metadata supplied by the publisher feed · Published Jul 7, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Rapamycin and Pharmacogenomics in Niemann-Pick C

0:00 20:41

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JIMD Podcasts?

This episode is 20 minutes long.

When was this JIMD Podcasts episode published?

This episode was published on July 7, 2026.

Can I download this JIMD Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!